Manufacturers of the anticoagulant drug Xarelto are facing lawsuits throughout the nation. Many people who have taken Xarelto have been seriously harmed by the anticoagulant (blood thinner). While all blood thinners carry the risk of internal bleeding, Xarelto lacks an antidote to stop the bleeding when it starts.
What is Xarelto?
Xarelto is a “once a day” pill prescribed for a condition that affects about 3 million Americans called atrial fibrillation. This condition causes blood to pool in a storage chamber of the heart where it can clot and travel to the brain. Xarelto was developed by Johnson & Johnson with Bayer AG to prevent this from happening.
Johnson & Johnson is expected to face mounting lawsuits because of claims that they were aware of the dangers of Xarelto, yet they continue to market their product aggressively, claiming it is safe. Xarelto is similar to another blood thinner, Pradaxa, that is also associated with bleeding accidents and heart problems. It is also associated with numerous lawsuits.
Still, the manufacturer continues to market Xarelto with its uncontrolled bleeding dangers that could allow even a minor accident to become very serious, very quickly. Pending lawsuits allege that the manufacturers engaged in:
- failure to warn about the known dangers of the drug; and
- unreasonable marketing of an unsafe drug.
As a result of these aggressive marketing efforts, nearly 130,000 prescriptions in the U.S. were filled within the first three months that the drug was on the market. Johnson & Johnson received huge profits from this.
However, people on the receiving end of these prescriptions were at increased risk for life-threatening bleeds during the time they used the drug, and most were not even aware.
Recently, The Huffington Post reported that top heart doctors throughout the U.S. had grave concerns about both of the newer blood thinners on the market: Xarelto and Pradaxa. Xarelto was allegedly linked to 968 adverse events (including 72 deaths) during the first 8 months of 2013. In 2012, Xarelto was linked to 750 adverse events, including 58 deaths. The Institute for Safe Medication Practices, an organization that is dedicated to safe medication use and protecting the public,
“identified 356 reports of serious, disabling, or fatal injury in which rivaroxaban